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Abstract
The scientific clinical trial of the African traditional medicine, Sutherlandia (Lessertia fru-
tescens) forms an interface between the indigenous local knowledge of people living with 
Aids, traditional health practitioners and that of science and global health. up till now, no 
cross-disciplinary studies have been done on epistemological questions concerning especially the 
knowledge and understanding of ‘proof ’ of efficacy concerning an African traditional medicine. 
This paper draws together insights and analysis from the anthropology and sociology of health 
and healing in discussing the intersecting fields of knowledge and experience of pharmacology, 
phytotherapy and related fields, as well as that of biomedical and traditional health practitio-
ners, and of research subjects involved in the making of clinical trials of sutherlandia (lessertia 
frutescens) in South Africa.
Keywords: South Africa, African medicine, bio-medicine, sutherlandia (lessertia frutescens) 
clinical trials.  
Introduction
Traditional herbal medicines, generally considered as naturally-occurring plant-derived 
substances with minimal or no industrial processing that have been used to treat illness 
within local or regional healing practices (Cravotto et al, 2010) receive significant 
attention in global health debates. This attention seems, of recent, to centre more on 
randomised clinical trials (RCT) of these medicines, which still remain the prevailing 
source of healing in most part of Africa with an estimated 80% of people using them.1
Generally, the standard call is for evidence-based research of herbal medicines in 
relation to quality, efficacy and safety, or in terms of well-defined close/effect relationships. 
The supporting evidence that is needed revolves chiefly around well-controlled clinical 
trials including placebo-controlled trials, where appropriate and, bioavailability and 
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pharmacokinetic studies. Such trials tend to receive generous funding from governments, 
pharmaceutical companies and herbal entrepreneurs. For example, China, India, Nigeria 
and the US are said to have made substantial investments in traditional medicine 
(WHO, 2002). South Africa made the provision for the investigation of traditional 
medicines (Pefile, 2005) in its national drug policy, and, in several African countries, 
there is an active promotion of traditional medicines for the treatment of HIV and 
associated symptoms by Health Ministries (Morris, 2002, Mills et al, 2005).
However, as the ever-expanding literature shows, randomised clinical trials of 
traditional herbal medicines remain controversial especially its underlying assumptions: 
the power and superiority of its mode of evaluation of efficacy. Some consider clinical 
trials as epistemologically problematic rejecting the notion that herbal medical 
treatment can be evaluated by scientific methods (Mackenzie-Cook, 2006). The premise 
for this is that science-based medicine is considered reductionist, whereas traditional 
herbal medicine is vitalistic (Coulter and Willis, 2004) and as such, it is problematic 
to evaluate the efficacy of traditional plants according to the criteria of evidence-based 
science. In addition, efficacy and safety are often evaluated “with different point of views 
and filtered by different opinions according to the clinical or traditional experience in 
the various folk medicines in different European countries” (Calapai, 2008: 428 citing 
Mahady, 2001). These observations, one may argue, remain in the tradition of the 
ancient ruminations on the extent to which medicine is a science and an art, a duality 
which Montgomery, in her recent volume how Doctors Think – Clinical Judgment and the 
Practice of Medicine, noted as a reminder that medicine remains poorly defined. Others, 
who stress the politics in this medical epistemology, see it as an extension of the politics 
of knowledge domination by the West through the strengthening of the long-standing 
‘hegemony’ of bio-medicine. 
At the heart of this strengthening ‘agenda’ is the special room given to traditional 
herbal medicines – complementary and alternative medicines (CAM), a term that is 
considered as reflecting the hegemony and indeed suggests hierarchies of knowledge. 
An opposing view, of this politics of knowledge, is what can be termed the ‘preservation 
stance’. In this view, it is held that indigenous medical knowledge must be protected 
and preserved and organisations such as the Dakar (Senegal)-based Association for 
the Promotion of Traditional Medicine (PROMETRA) dedicates itself to preserving 
and restoring African traditional medicine and indigenous science. There are those who 
disagree with this view dismissing traditional medicines on the ground that it is based 
on ‘superstition and neocremancy’, suggesting instead that herbal medicines should be 
‘co-opted’ into bio-medical knowledge and researched for this purpose as they “would 
not only improve and demystify its therapeutic qualities” (Nyika, 2007: 25), but “provide 
validated information to traditional healers and patients on” their judicious use (Mills, et 
al, 2005: 1). Such a view, one must hasten to add, seeks to standardise and control that 
which hardly falls within biomedical modality of knowing.
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In the pages to follow, the above issues are discussed within the general theme of 
knowledge, healing and medicinal plants drawing together insights and analysis from 
anthropology and sociology of health and healing. The literature on this is verse and 
it is not the objective here to attempt to cover the topics nor provide an authoritative 
review of the debate; my task is simply to present a relatively sustained examination and 
discussion of the more salient ones – the increasing clinical trials of herbal medicines 
as part of the ‘movement’ to give it a science base; the ethos of healing of traditional 
medicine and its incompatibility with the ethos of bio-medicine. The objective is to bring 
to the fore the dilemmas, difficulties, challenges in the quest for the treatment of chronic 
diseases in a context in which the vast majority rely on traditional herbal medicine but 
science and scientific methods are accepted as the major foundations for health care 
and biomedical knowledge inform health policy. The key point is: clinical trials’ ‘logic of 
refutation’ would seem to provide, epistemologically, a partial knowledge of the efficacy 
and safety of traditional medicines based strongly on the traditional healing’s ‘logic of 
affirmation’, which is readily dismissed by the former. Both require rigorous examination 
in the quest to establish a plant’s efficacy; defining all potential warrants for medicine-
making in clinical trials strengthens the efforts to structure hierarchies of knowledge that 
denote and devalue knowledge derived from anything other than rigorously conducted 
clinical research.  It is an old call but given that there has not been any intellectual 
resolution that can serve as a platform on which biomedicine/traditional healing can 
jointly proceed to achieve optimal practice of medicine in the context described earlier, 
the current piece aims, modestly, to stimulate further philosophical  inquiry for that 
purpose. The discussion draws also  from an on-going ‘conversation’ with traditional 
health practitioners in a UWC-PEPFAR project2 that brings together bio-medical and 
traditional health practitioners in dealing with HIV/AIDS as well as from phytotherapy, 
considered as a complementary approach to healing and preventing disease. 
The paper is an outgrowth of an ongoing study of the philosophy and environment 
of clinical trials of sutherlandia. The discussion is structured as follows: the first section 
deals with herbs and the scientific testing of their safety and efficacy in the form 
of clinical trials. This is followed by the section in which traditional medical health 
system is discussed, specifically, its knowledge base. These sections set the context for a 
discussion of an African herbal plant, the sutherlandia, and the clinical trial of this plant 
is examined against the issues raised in the sections. These are all brought together in the 
last section which raises some questions with the purpose of showing the complexities 
of the making of a medicine in a context where most patients utilize the services of 
traditional healers. 
Herbs for medicines and clinical trials of herbs
Generally, herbs can be any form of a plant or plant product including 
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leaves, stems, flowers, roots and seeds. As such they are often perceived as 
‘natural’ and thus somehow safe (Ernst, 2002).These plants can either be sold raw or 
as extracts, where they are mace rated with water, alcohol or other solvents to extract 
some of the chemicals. The resulting products contain dozens of chemicals, including 
fatty acids, sterols, alkaloids, flavonoids, glycosides, saponins, and others (Bent, 2008). 
However, many different side effects to herbs have been reported and recently reviewed 
(De Smet, 2002). A common toxity to herbal medicines involve pyrrolizidine, alkaloids, 
which are complex molecules found in certain plants that may be used or inadvertently 
added to herbal medicines. These alkaloids produce hepatotoxity through a characteristic 
veno-occulsive disease that may be rapidly progressive and fatal (Stickel, Patseuker and 
Scuppan, 2005). Yet, herbal medicines are reported to have no-side effects except in 
cases where the herbs are used with synthetic drugs. Some herbs, as De Smet (2002) 
notes are known to interact with pharmaceutical drugs. St John’s wort, for example, 
is said to be the most notoriously interactive herbal product, and has been shown to 
interfere with numerous drugs metabolized by the cytothrome P-450 liver enzyme 
system, including protease inhibitors, chemotherapeutic agents and oral contraceptives 
(see, for example, Nebel et al, 1999; Prost et al, 2000).Some authorities note that many 
herbs, including Kava, Valerian and St John’s wort, have the potential valerian to interact 
with anesthetic agent s and other drugs given in the perioperative period (Ang-Lee, 
Moss, Yuan, 2001). One must, however, state that the true frequency of side effects 
for most herbs is not known because they have not been tested in large clinical trials 
and also because surveillance systems are much less extensive than those in place for 
pharmaceutical products (Bent, 2008). 
Some researchers consider herbal medicines as not fulfilling the requirements of 
well established medicinal use despite the long tradition of use. The adverse effects of 
phytotherapeutic agents are less frequently compared with synthetic drugs; however, well 
controlled clinical trials and numerous individual case reports have now confirmed that 
such effects do exist (Calixto, 2000). One cannot rule out the fact of the longstanding use 
of herbal medicines as a guarantee of their safety. At the same time, one cannot say that 
because of this, there safety and efficacy cannot be questioned. The question therefore is: 
what is the level of acceptable safety and efficacy? This question raises a general problem: 
the evaluation of efficacy. According to what criteria? Generally and principally, as 
has become quite known, it is according to the criteria of evidence-based medicine. 
As suggested by Calapai and Caputi (2007), the efficacy of medicinal plants can be 
tested in clinical trials much like synthetic drugs, although numerous methodological 
and logistical problems exist. The methodological issues include research design. 
There is a consensus that all human subjects research must ‘maintain valid study designs’, 
however, the characteristics of a valid research design would seem to be an issue. There is 
the argument, especially by those trained in biomedical methods of clinical investigation 
that the only valid source of knowledge regarding clinical efficacy must come from one 
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type of research design: the randomised blind, placebo-controlled trial (Tilburt and 
Kaptchuk, 2007).This is considered a gold-standard and any deviation from it makes 
the research worthless.
There is an opposing view which suggests that the attempt to evaluate traditional 
therapies with biomedical methodologies, may fail to generate true knowledge since 
that knowledge itself depends on a scientific vocabulary that only makes sense within 
the concepts of biomedicine (Schaffner, 2002; Fabrega, 2002).They suggest that the 
“standard notions of experimental design criteria represents an imperialistic ‘western’ 
mode of thinking” (Schaffner, 2002, p7). Kaptchuk (2001) suggested that research on 
herbal medicines should typically employ experimental research designs such as the 
RCT, even if research tools are not perfect; they are, in fact considered the best methods 
for furthering knowledge. What we, therefore, have is that clinical trials of herbal 
medicines continue with its tradition of ‘trials’ – science’s tradition. The trials maintain 
focus on safety and efficacy hardly showing interest in the cultural context of the use of 
such plants. What is the cultural context of the use of such plants? Of what benefit is 
the cultural context to the issue of efficacy and safety? In asking these questions, one is 
invariably asking questions of the knowledge base of traditional medical practice. What 
is this knowledge base? The answer is well-known as so much has been written; what 
can be done for the purpose of the discussion at hand is to present the core. This is done 
within the context of what can be considered as the traditional health system and this 
follows immediately.
Traditional Medical Practice and its knowledge base
Forster’s (1976) notion of ‘personalistic’ serves as a useful starting point in describing 
the traditional medical system. In such a system, illness and misfortune can be caused 
by the purposeful manipulation of supernatural powers so that the religious and 
medical systems are intermeshed. Personalistic etiologies are based on the idea that the 
volition or the intervention of an extra-natural force causes misfortune. The treatment 
of personalistic illness is the specialty of the traditional healer who conducts healing 
ceremonies aimed at appeasing angered gods or spirits, or counteracting the influence 
of witches or others who possess the power to cause illness. On this point, one needs 
to point out that in as much as a deity, a human witch or sorcerer, or non-human agent 
such as an evil spirit or ancestor can use powers beyond those of everyday experience 
to harm living human beings or control their behaviour, the converse applies in that 
the same powers can be proactive and assure success in life to those who possess 
them. Given this, the medical practitioner in this system, referred to, generally as 
the traditional healer is “someone who is recognised by the community in which he 
{she} lives as competent to provide health care by using vegetable, animal and mineral 
substances and certain other methods based on social, cultural and religious background 
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as well as the prevailing knowledge, attitudes and beliefs regarding physical, mental 
and social well-being and the causation of disease and disability in the community” 
(WHO, cited in Pretorious et al 1993). Obviously if such a person is responsible 
for disease and disability, then, he is a sorcerer, which then suggests that a sorcerer 
in this system is also considered a medical practitioner. This explains why the African 
traditional medical practitioner is various referred to as herbalist, native doctors, native 
healer, traditional doctor, medicine man, witch doctor, among others.  
However, whether a healer or a sorcerer, a medical practitioner is an agent who is 
knowledgeable in culturally determined roles of procedure that can be used to control 
supernatural powers to bring about predetermined effects for self or client. The 
assumption is that these forces are part of a coherent interconnected universe in which 
acts of magic can project specific forces along pathways or connections between things 
to bring about desired goals. When there is interference with the cause of natural forces 
which results in action contrary to their ‘natural programme’, we can then say that there 
has been sorcery as Stevens (1996) also pointed out. It is important to note that Stevens 
(1996: 723) conceptually separate the forces of nature that can be magically programmed 
for a specific action from the powers of the anthropomorphised deities, ancestors, ghosts 
and spiritual beings that also inhabit the universe. Medical practitioners in personalistic 
systems are skilled in controlling natural forces and some also can capture the services 
of spirits.  This is part of their very rich repertoire in preparing medicine. Included 
in this repertoire in some cultures are human images molded or carved from natural 
materials and used as conduits to channel the powers of nature toward cultural goals of 
‘magical mimesis’ which, according to Taussig (1992), involves “both copy and substantial 
connection, both visual replication and material transfer” (Taussig, 1992: 8-14). 
The making of medicine in this system is thus one in which the entire natural world is 
a source of power. Practitioners, therefore, incorporate plant and animal parts and other 
natural objects, as well as artefacts in varying combinations to draw upon the unique 
powers of each. The parts of plants and animals used tend to be what Rubin (1989) 
described as “signature elements”. These include the leaves, roots of the plants, bark 
as earlier mentioned. In cultures where human figures are used as part of the making 
of medicines, such figures are more than mere imitations. As Wolff (2000) keenly 
observed, in the case of the place of human figures in the medicines of the Yoruba 
of South-western Nigeria, such figures are transformers that embody and channel the 
powers of the natural materials from which they are fashioned. In other words, he adds, 
enthusiastically, that the creation of the medicine figure is an act of embodiment with 
the intention of concentrating powers of nature for social goals. Most of these medicine 
figures must be further empowered, which was also noted by Wolff, before they fulfill 
their instrumental function. This can either be through putting them in contact with 
the additional magical ingredients and/or by having powers called into them through 
sacrifice and incarnations.
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There are other similar practices in sub-Saharan Africa. Wolff (2000) notes that, one 
of the best documented traditions of the medical use of human images as power objects, 
is that of the Kongo. He writes that Kongo medical practitioners make minkisi figures 
with magical ingredients inserted into wood or applied as thick mantles to the surfaces. 
It is known that such figures, when carved in human form, can be charged with positive 
curative or protective forces or conversely with destructive powers to bring misfortune 
or disaster to enemies. We see this also in the role of esu in Yoruba medicine (Oloyede, 
1999). As Wolff (2000) was correct to point out, in the larger inventory of the Yoruba 
sculpture in which the human figure is the leitmotif, the carved and modeled human 
images in indigenous medicines form a small and obscure category. However, their use 
in making medicines is huge; yet, it is herbal plants that are central in making medicines. 
In this regard, traditional healers are skilled botanists and have great talent for locating 
plants with medicinal properties. 
In the conversations with traditional health practitioners in an ongoing 
research that was referred to earlier, they point out that their preference for 
sourcing the plants remains the village groves, jungles and the generally wild. 
This is based upon the belief that wildly collected materials are more effective 
than planted ones. This point is very crucial in the making of herbal medicines. 
Interestingly, scientific studies, seem, to some extent to support this assertion. Medicinal 
properties in plants are due mainly to the presence of secondary metabolities that 
plants need in their natural environments under particular conditions of stress and 
competition, which perhaps would not be expressed under monoculture conditions. 
Active ingredient levels can be much lower in fast growing cultivated stocks. In wild 
populations, plants can be older due to slow growth rates and can have higher levels of 
active ingredients. This scientific explanation is culturally explained by traditional health 
practitioners as simply part of the healing power of nature and only those trained who 
possess the skill and knowledge are directed to the plants in their natural habitat. In 
fact most personalistic illnesses can be treated only by traditional healers because they 
know the proper rituals part of which include gathering the appropriate herbal plants. 
While one can presume that cultivated plants are likely to be somewhat different in 
their properties from those gathered from the natural habitats, it is also clear that certain 
values in plants can be deliberately enhanced under controlled condition of cultivation. 
This is a very crucial meeting point of traditional herbal medicine and biomedicine 
at which difficulty of ‘togetherness’ somehow emerges.  Most standard pharmacological 
evaluations of medicinal plants tend to support the use of traditional medicines but fall 
short of suggesting that efficacy must be culturally appropriate. Scientific clinical trials 
are supposed to provide ‘proof ’ of efficacy and allow these medicines to be admitted into 
evidence-based medicines. 
However, from the discussion in the earlier part of this section, what works in 
traditional herbal medicines would seem to include transcendent, transformational 
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experiences, changing lived-body experience and the gaining of meaning. Traditional 
medical practitioners have in fact been referred to as “excellent psychologists” (Crawford 
and Lipsege, 2004) in that their therapy is so widely regarded as successful because 
psychosocial issues are addressed and as such the “meanings of sicknesss events become 
a social issue” (Goody, 1977) thus interpreted as structural microcosms of the society as 
a whole (Swedlund and Armelagos, 1990).  Of what use, therefore, is the clinical trials of 
herbal medicines? Apart from the efficacy and safety issue, some have suggested that there 
are practical benefits because biomedical criteria can generate valuable new interpretations 
for comparative studies of human physiological processes, the ways in which such 
processes are perceived and the culture-specific behaviours that these perceptions produce. 
An example of this point would be Browner, Ortiz de Montellano and Rubel, (1988: 
683). These authors developed a model for analyzing ethnomedical data independently 
as well as according to the standards of biomedicine. 
The first step in their model is to identify the phenomena under investigation in emic 
terms. In the second step, one determines the extent to which the phenomena described 
can be understood in terms of biomedical concepts and methods. The third and final 
step is to identify the area of convergence and divergence between the emically described 
phenomena and their biomedical understandings. At this stage, biomedical concepts are 
used not to examine the phenomena in their own terms (as in the second step) but to 
see if they are consistent with biomedical assumptions. Etkin (1988) suggested how 
efficacy can be measured culturally in what is a seminal piece in this regard. He defines 
efficacy as “something that works by directly producing a set of required, culturally 
defined outcomes” (p30) and suggested that the key to any consideration of efficacy is 
the distinction between its emic and etic interpretations. The efficacy of medicinal plants 
may be judged in their ability to induce full remission of symptoms.  One notes this 
particular point in the conversations with traditional healers on the UWC-PEPFAR 
project. The efficacy of medicinal plants is judged not so much because they have been in 
use for generations but their ability to induce full remission of symptoms. Physical signs 
such as fever salivation are important indicators that a plant has initiated the healing 
process. 
Ortiz de Montellano and Browner (1985) both developed a method for assessing 
the efficacy of medicinal plants according to both indigenous understanding of their 
therapeutic effects and the standards of biomedicine. The first step in their method 
requires investigating informants’ own understandings of illness aetiology to predict 
what medicines would be considered appropriate for their treatment. These ethnomedical 
data are then combined with data on chemical constituents, physiological effects and 
biomedical concepts that constitute ‘confidence levels’ for the efficacy of plant medicines. 
Level I comprise reported folk use. Multiple reports of use by populations widely 
dispersed through space, or persistent reports over long periods of time, increase the 
probability that a plant will exhibit pharmacological activity. Level II plants meet the 
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criteria of Level I and show the desired activity of the isolated compounds or extracts 
in in vitro or in vivo tests. At Level III, plants satisfy Level II requirements and show 
a plausible biochemical mechanism by which the active constituents could exert the 
indicated physiological effect. Finally Level IV plants fulfill the criteria for Level III and 
have been clinically tested, or are commonly used in medicine. Information on a plant’s 
level of confidence is then considered in the light of its emic evaluation of efficacy. This 
method would seem to go the distance in terms of understanding of the therapeutic 
effects of medicinal plants, but in practice, are clinical trials conducted along what is 
suggested? For this, we examine the clinical trial of a herbal plant using one of such trials 
at the South African Herbal Science and Medicine Institute (SAHSMI). 
SAHSMI and the Clinical Trial of Sutherlandia
The South African Herbal Science and Medicine Institute (SAHSMI) based at the 
University of the Western Cape in Cape Town conducted what could be considered the 
first randomised double-blind, placebo-controlled trial of sutherlandia in healthy adults 
in the country.  The Institute which houses the International Centre on Indigenous 
Phytotherapy Studies (TICIPS), a global centre on indigenous medicine funded by 
the National Centre for Complementary and Alternative Medicine (NCCAM) of 
the National Institutes of Health (NIH) in Washington, DC, USA., conducts clinical 
trials of herbal plants in collaboration with the School of Medicine at the University of 
Missouri in the US, the Nelson Mandela Medical School of the University of Kwazulu-
Natal in Durban, South Africa, the Institute for Infectious Diseases and Molecular 
Medicine (IIDMM) of the University of Cape Town in South Africa, the Medical 
Research Council (MRC) of South Africa. This collaborative endeavour is rooted in 
biomedical culture in that what is sought in the clinical trials are evidence for efficacy and 
safety. Such evidence is informed by the idea that building a valid basis for knowledge 
in herbal medicine will require balancing two aspects of scientific validity: internal and 
external validity (Cravotto; Boffa; Genzini and Garells, 2010). Internal validity means 
that the research must reliably test hypothesized relationships between an intervention 
and outcome under controlled conditions. Internally valid research will typically try to 
answer a focused research question that is salient within the vocabulary and a method 
of scientific community at the time the research is conducted. External validity refers to 
the applicability of the research results to a target population outside the experimental 
conditions of the research study. External validity must always be weighed against the 
need for rigorous internally valid research.
The clinical trial of sutherlandia, a shrub that belongs to the Fabeca family, at SAHSMI 
was along this line (see Quinton et al 2007). Surtherlandia is principally constituted 
of L.-canavanine, a non-protein amino acid. Gericke et al (2001) note that there is 
about 30-40 mg of L-canavanine per dry gram of the S. frutescens leaf.  Other principal 
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constituents are GABA, and D-pinitol. The latter is a type of sugar ‘found in many 
types of legumes and is classified as a chiro-inositol. It is also known as 3-O-methyl-
D-chiro-inosotol, or 3-0-methyl-1,2,4 cis-3,5,6 trans-hexahydroxyl-cyclohexanol 
(Mills et al, 2005) GABA (gabba-amino butyric acid) is both an amino acid and inhibitory 
neurotransmitter. It is found at levels of 14 mg per gram dry leaf of S. frutescens (Gerike 
et al, 2001). Sutherlandia is indigenous to South Africa and is widely used in the country 
as traditional medicines “since they were first adopted by the Khoi, San, and Nama 
peoples” ( Johnson et al, 2007:0002). Like most traditional herbal medicines, its usage 
is not confined to the treatment of a single illness but several illnesses such as cancer, 
tuberculosis, diabetes, influenza, rheumatoid arthritis, osteoarthritis, peptic ulcer and in 
the current era of HIV/AIDs, some of the associated symptoms like nausea (Gericke 
et al, 2001; Dalvi, 2003; Johnson et al, 2007). The various names given to it by different 
ethnic groups in the country reflects its wide usage. We are told that it is referred to as 
unwele, Lerumo-lamadi, unwele, kankerbos, kankerbossie (Mills et al, 2005 citing Gericke 
et al, 2001; Dalvi et al 2003).  Sutherlandia does not have any rules that govern its use like 
most herbal plants that are widely sold in the country. Consequently, the absence of any 
form of regulation has meant that the harmonization of its use could also be considered 
as an issue. Its importance for clinical trials lies, partly, in this. 
 The objectives of the clinical trials at SAHSMI were twofold: to conduct a pilot 
study of the safety of sutherlandia in healthy adults and secondly, to contribute 
to establishing procedures for ethical and scientifically {emphasis mine} rigorous 
clinical trials of African indigenous medicines. The design was a randomised, 
double-blind placebo-controlled trial of sutherlandia leaf: 12 participants were 
randomised to a treatment of 400mg capsules of sutherlandia leaf powder, 
13 individuals were randomised to consume a placebo capsule, each receiving 180 
capsules for the 3 months duration of the trial which was at the Tiervlei Trial Centre of 
the Karl Bremer Hospital in Bellville, Cape Town, South Africa. Clearly, what we see 
here is that when medicinal plants with biologically active constituents are the focus of 
study, biomedical researchers fail to consider the cultural contexts within which plants 
are used with the result that efficacy of a plant is misunderstood (Walstein and Adams, 
2006). Can one say this of the scientists at SAHSMI. The scientists at SAHSMI 
will probably argue that they are aware of the cultural context and that given the 
challenges posed by the ‘medication of HIV/AIDs crisis’, effective crisis intervention is 
dependent on accurate assessment that directly translates into focusing treatment when 
it is needed. They will go on to point out that the philosophical basis of clinical trials 
at the Institute is not just about providing the evidence of the efficacy and safety of 
traditional medicines, rather, it is about enhancing the well-being of the patients’ safety 
and cure of disease, which, keen observers would not hesitate to point out that, though 
commendable, is hardly different from what biomedical researchers would generally say. 
The scientists know very well that traditional as well as biomedicine is integral 
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components of the health care delivery system in the country and indeed, in several 
African countries. One can suggest that that they will also know that the individual’s 
interaction with other sectors of health care depends on how the health problem is 
perceived or sanctioned by the sick person and most importantly by relatives and close 
friends as shown by Crawford and Lipsege’s exploratory study of the identification 
of psychological distress among the Zulu people in South Africa (2004). Depending 
upon the prevalent symptoms of illness, a person may choose to disregard an illness 
or heath problem, use treatment modalities known to the individual, friends or family 
or make decision to use services of a traditional medical practitioner or biomedical 
health practitioner (Tabi et al, 2006). Despite the ‘cultural awareness’ of the scientists at 
SAHSMI, there is still the difficulty of going beyond the narrow concern, as exemplified 
by clinical trials, with safety, efficacy and toxity of plants to a focus on how people 
use their knowledge of such plants – the uses to which people put their knowledge of 
the natural world and classification as it relates to their exploitation of it. This perhaps 
explains why SAHSMI sought anthropology and sociology in it’s broad interdisciplinary 
understanding of herbal medicines and clinical trials. 
Concluding Remark: Biomedical hegemony?  
Biomedicine is charged in the wider critique of the continuing hegemonic domination 
of the West over all aspects of life outside the western world. This is not without 
foundation. In a penetrating piece on applied ethnobiology, Sillitoe (2006) notes that 
“the term ethnobiology did not come into use until the twentieth century. Naturalists 
have shown an ‘interest’ in local biological knowledge since the time Europeans started 
to explore the world from the fifteenth century onwards. Indeed this knowledge 
informed biological science from early on, as witnessed in the research by Linnaeus, 
who corresponded with people around the world, and Rumphius’ work in Southeast 
Asia. In a sense, we can interpret this as ….. Europeans not only sought to understand 
the new regions they invaded but also were on the lookout for resources that they might 
profitably exploit engaging practices that today we should consider tantamount to 
biopiracy………. Those who engage in bio-prospecting, hoping for example, to find 
elsewhere plants with unknown medicinal or cosmetic properties, are also current-day 
descendants of this tradition, although from a humanistic perspective such work gives 
rise to worries about theft of others’ knowledge”. Would this explain the non-availability 
of the traditional healers’ knowledge for scientific inquiry and its concomitant dismissal 
that it does not have scientific legitimacy? 
It is very clear in the vast literature on traditional healing that in the ‘clinical setting’ 
of traditional healing, the encounter between the traditional healer and the patient is 
not necessarily between the two: both ancestors are involved. The clinical reasoning of 
the traditional healer is thus a multilayered process of the interaction in the clinical 
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setting which reveals to the traditional healer certain ‘signs’ of which the bodily signs 
is a part and interpretations thereof, as well as the consultations with the ancestors for 
the understanding of the patient’s ’disequilibrium’ and what to do to bring it back to 
the state of ‘equilibrium’. This epistemological complexity of understanding shows that 
what is ‘prescribed’ is specific to the patient as an individual person, not as a body and 
as such would hardly yield itself to the efficacy sought through clinical trials that are 
controlled, measured and regarded as valid. Traditional medical healing modality, one 
must emphasise, has withstood the test of time but, perhaps, not the test of science, 
which is still grappling with the mind-body interconnections. In the traditional healers’ 
view, clinical trials may yield an understanding of the herbs but this is not equivalent to 
the understanding of the patient’s state of ‘person-disequilibrium’. To them, this cannot 
be ignored when talking about efficacy of herbs.  
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End Notes
1 The traditional medicine system in Africa includes herbal remedies for 
specific diseases, folk knowledge, traditions and values, health behaviours 
and patterns.
2 The UWC-PEPFAR-CDC Project 7 is specifically concerned with the 
training of traditional healers and biomedical health professionals in dealing 
with HIV/AIDS. It is an attempt to bring together both health practitioners 
within the context of a wider science-traditional medicine paradigms 
engagement/meeting. 
